Skip Navigation

ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Judd Berman

Judd Berman

Judd Berman is currently chief scientific officer of Dalton Medicinal Chemistry and a co-founder and consultant to Nobelex Biotech, Inc. located in Toronto, Ontario, Canada. Prior to this he was chief scientific officer at Affinium Pharmaceuticals (structure guided anti-infectives) and he had various roles in Chemistry at GlaxoSmithKline (Research Triangle Park) specialised in metabolic diseases, target class research, cancer research and benign prostatic hyperplasia. He began his career at the Merrell Dow Research Institute, working on cardiovascular diseases. The author and inventor of more than sixty articles and patents, Berman received his PhD in organic chemistry from the University of California, San Diego.